Biogen grabs Apellis for $41/share + CVR. Deal closes, signaling M&A activity.
BYD eyes EU plants amid Stellantis' EV write-down; valuation risks loom for legacy brands.
BMBL's Q1 beats EPS/EBITDA but revenue dips. Margin jumps 12.6 pts. Users down 848k.
Brent crude jumps 6% on Iran tensions & China buying hopes, but Strait risks loom.
DFIN's Q1 beat EPS but missed EBITDA; Q2 guidance disappoints. Stock drops 17%.
US 30-yr yields top 5%, highest since '07. Fed battles inflation, pushing Treasury yields higher.
Bristow Group's EPS misses despite revenue beat; costs bite profits. Guidance affirmed, but watch margins.
Sponsored
Must Read